Filial #1 Regional Oncology Dispensary of Nizhniy Novgorod

Nizhny Novgorod 603081

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Non-Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) — Completed
• A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) — Stopped early